News

Yale Journal of Biology and Medicine Interview with Head of AFCR-Supported Translational Cancer Research Project

We have completed six studies in the US and now we are doing an international clinical trial with a target population of hepatocellular carcinoma, which is the major type of liver cancer in Asia… Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309656/...

Read more

10 Ways Your Diet Can Reduce Your Cancer Risk

A healthy diet can impact many areas of health. A poor diet can increase the risk of the six most common types of cancer worldwide. There are many different sources telling many different stories about what a healthy diet and lifestyle look like. While there are many ways to achieve…...

Read more

Personal Discipline and Perseverance Are Still the Best Practice to Prevent COVID-19 in 2020 Amid the Uncertainty of Protective Vaccine Availability

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Excitement spread quickly after a June 14 report that a COVID-19 vaccine developed by Imperial College London in the U.K. will be tested in humans. What excites people is that the vaccine, which is based on a cutting-edge technology called…...

Read more

Will This Drug Relight the Dimming Hope of Finding Effective Therapies for COVID-19?

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board Many people were disappointed by recent high-profile clinical trial results on Remdesivir, the drug that people had put high hopes on as the best candidate for an effective COVID-19 treatment. A report published in The New England Journal of Medicine on…...

Read more

Can Vaccines Win the Race Against the Novel Coronavirus?

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board The U.S. death toll has passed the 100,000 mark this week, but effective anti-viral drugs are still not available for the treatment of COVID-19. Rather, many people have been putting their hope on the development of vaccines as Dr. Anthony…...

Read more

Don’t Ignore These Ovarian Cancer Related Symptoms

Often known as “the silent killer”, ovarian cancer is difficult to detect early because the ovaries are deep within the pelvis and initial symptoms are often ambiguous and non-specific. Too often the cancer goes undiagnosed until after the disease is far advanced and has spread throughout the abdomen or to…...

Read more

Better Treatment Is on the Way as Doctors Know More about the Tricks of Novel Coronavirus

Michael Wang, MD., Ph.D., member of AFCR Scientific Advisory Board On February 11, weeks into the COVID-19 outbreak, the novel coronavirus was officially called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as most patients showed mild to severe respiratory illness. Doctors shared the same concept, based largely on commonly observed…...

Read more

AACR Virtual Annual Meeting I presents new data on cancer biology, treatment, screening, risk reduction

Brief points covered in the America Association for Cancer Research (AACR) Virtual Annual Meeting I held on April 27-28th: -Treating BRAF-Positive Melanoma by adding checkpoint inhibitor Tecentriq (atezolizumab) to a combination of two targeted drugs Zelboraf (vemurafenib) and Cotellic (cobimetinib) -PARP Inhibitor (targeted drugs that inhibit DNA damage repair) are…...

Read more

Link between Children with Cancer and COVID-19

May 16th, 2020 A study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths. Read more at: https://www.cancertodaymag.org/Pages/cancer-talk/May-15-The-Week-in-Cancer-News.aspx...

Read more

FDA Approves Pemazyre (Pemigatinib) for Bile Duct Cancer

The US Food and Drug Administration (FDA) approved the first targeted therapy for bile duct cancer. Pemazyre (pemigatinib) is for adults with advanced bile duct cancer whose cancer has grown after at least one previous chemotherapy treatment and whose tumors have a mutation in the FGFR2 gene. Full information at: https://www.cancer.org/latest-news/fda-approves-pemazyre-pemigatinib-for-bile-duct-cancer.html...

Read more